Concepedia

Carlos Gómez-Martín

CG

24

Publications

2.1K

Citations

17

H-Index

1998

Active since

Affiliations

Hospital Universitario 12 De Octubre(Current)

Research Institute Hospital 12 de Octubre

Spanish National Cancer Research Centre

Clinica Universidad de Navarra

Hospital Universitario HM Sanchinarro

Carlos Gómez-Martín is an author at Hospital Universitario 12 De Octubre specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

1998–2024

24

Publications

24

A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C

Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata et al. · Journal of Hepatology · 2013 · 977 citations

, , +12

Level of <i>HER2</i> Gene Amplification Predicts Response and Overall Survival in HER2-Positive Advanced Gastric Cancer Treated With Trastuzumab

Carlos Gómez-Martín, Carlos Plaza, Roberto Pazo-Cid et al. · Journal of Clinical Oncology · 2013 · 195 citations · Full text

Efficacy and Safety of Sorafenib in Combination With Mammalian Target of Rapamycin Inhibitors for Recurrent Hepatocellular Carcinoma After Liver Transplantation

Carlos Gómez-Martín, Javier Bustamante, J.F. Castroagudı́n et al. · Liver Transplantation · 2011 · 161 citations · Full text

SARS-CoV-2 infection in cancer patients undergoing active treatment: analysis of clinical features and predictive factors for severe respiratory failure and death

Ramón Yarza, Mateo Bover, D. Paredes et al. · European Journal of Cancer · 2020 · 98 citations · Full text

HER2/ <i>neu</i> testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

Carlos Gómez-Martín, Elena Garralda, María José Echarri et al. · Journal of Clinical Pathology · 2012 · 91 citations · Full text

Rows per page

1–5 of 24